These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10542293)

  • 1. Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors.
    Proudfoot AE; Buser R; Borlat F; Alouani S; Soler D; Offord RE; Schröder JM; Power CA; Wells TN
    J Biol Chem; 1999 Nov; 274(45):32478-85. PubMed ID: 10542293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activation of CC chemokine receptors by AOP-RANTES.
    Elsner J; Mack M; Brühl H; Dulkys Y; Kimmig D; Simmons G; Clapham PR; Schlöndorff D; Kapp A; Wells TN; Proudfoot AE
    J Biol Chem; 2000 Mar; 275(11):7787-94. PubMed ID: 10713092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
    Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
    J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3.
    Chvatchko Y; Proudfoot AE; Buser R; Juillard P; Alouani S; Kosco-Vilbois M; Coyle AJ; Nibbs RJ; Graham G; Offord RE; Wells TN
    J Immunol; 2003 Nov; 171(10):5498-506. PubMed ID: 14607956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity.
    Mack M; Luckow B; Nelson PJ; Cihak J; Simmons G; Clapham PR; Signoret N; Marsh M; Stangassinger M; Borlat F; Wells TN; Schlöndorff D; Proudfoot AE
    J Exp Med; 1998 Apr; 187(8):1215-24. PubMed ID: 9547333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminooxypentane addition to the chemokine macrophage inflammatory protein-1alpha P increases receptor affinities and HIV inhibition.
    Townson JR; Graham GJ; Landau NR; Rasala B; Nibbs RJ
    J Biol Chem; 2000 Dec; 275(50):39254-61. PubMed ID: 11005816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminooxypentane-RANTES induces CCR3 activation and internalization of CCR3 from the surface of human eosinophils.
    Elsner J; Dulkys Y; Kimmig D; Wells TN; Proudfoot AE; Kapp A
    Int Arch Allergy Immunol; 2001; 124(1-3):227-9. PubMed ID: 11306977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner.
    Bochner BS; Bickel CA; Taylor ML; MacGlashan DW; Gray PW; Raport CJ; Godiska R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):527-32. PubMed ID: 10069890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A natural CCL5/RANTES variant antagonist for CCR1 and CCR3.
    Capoulade-Métay C; Ayouba A; Kfutwah A; Lole K; Pêtres S; Dudoit Y; Deterre P; Menu E; Barré-Sinoussi F; Debré P; Theodorou I
    Immunogenetics; 2006 Jul; 58(7):533-41. PubMed ID: 16791620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3.
    Elsner J; Petering H; Höchstetter R; Kimmig D; Wells TN; Kapp A; Proudfoot AE
    Eur J Immunol; 1997 Nov; 27(11):2892-8. PubMed ID: 9394815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils.
    Struyf S; Menten P; Lenaerts JP; Put W; D'Haese A; De Clercq E; Schols D; Proost P; Van Damme J
    Eur J Immunol; 2001 Jul; 31(7):2170-8. PubMed ID: 11449371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
    Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
    Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional expression of beta-chemokine receptors in osteoblasts: role of regulated upon activation, normal T cell expressed and secreted (RANTES) in osteoblasts and regulation of its secretion by osteoblasts and osteoclasts.
    Yano S; Mentaverri R; Kanuparthi D; Bandyopadhyay S; Rivera A; Brown EM; Chattopadhyay N
    Endocrinology; 2005 May; 146(5):2324-35. PubMed ID: 15718270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs.
    Torre VS; Marozsan AJ; Albright JL; Collins KR; Hartley O; Offord RE; Quiñones-Mateu ME; Arts EJ
    J Virol; 2000 May; 74(10):4868-76. PubMed ID: 10775626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants.
    Mosier DE; Picchio GR; Gulizia RJ; Sabbe R; Poignard P; Picard L; Offord RE; Thompson DA; Wilken J
    J Virol; 1999 May; 73(5):3544-50. PubMed ID: 10196243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why CCR2 and CCR5 blockade failed and why CCR1 blockade might still be effective in the treatment of rheumatoid arthritis.
    Lebre MC; Vergunst CE; Choi IY; Aarrass S; Oliveira AS; Wyant T; Horuk R; Reedquist KA; Tak PP
    PLoS One; 2011; 6(7):e21772. PubMed ID: 21747955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines.
    Hartley O; Dorgham K; Perez-Bercoff D; Cerini F; Heimann A; Gaertner H; Offord RE; Pancino G; Debré P; Gorochov G
    J Virol; 2003 Jun; 77(12):6637-44. PubMed ID: 12767983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II.
    Weber KS; Gröne HJ; Röcken M; Klier C; Gu S; Wank R; Proudfoot AE; Nelson PJ; Weber C
    Eur J Immunol; 2001 Aug; 31(8):2458-66. PubMed ID: 11500830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor.
    Struyf S; De Meester I; Scharpé S; Lenaerts JP; Menten P; Wang JM; Proost P; Van Damme J
    Eur J Immunol; 1998 Apr; 28(4):1262-71. PubMed ID: 9565366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage.
    Oravecz T; Pall M; Roderiquez G; Gorrell MD; Ditto M; Nguyen NY; Boykins R; Unsworth E; Norcross MA
    J Exp Med; 1997 Dec; 186(11):1865-72. PubMed ID: 9382885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.